Antisense Oligonucleotides in Cancer: Recent Advances

ISSN： 1173-8804

Source： BioDrugs, Vol.13, Iss.3, 2000-03, pp. : 195-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Future of Antisense Oligonucleotides in the Treatment of Respiratory Diseases

By Ulanova Marina Schreiber Alan D.

BioDrugs, Vol. 20, Iss. 1, 2006-01 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

A novel dysferlin mutant pseudoexon bypassed with antisense oligonucleotides

Annals Of Clinical And Translational Neurology, Vol. 1, Iss. 9, 2014-09 ,pp. : 703-720

John Wiley & Sons Inc

Access to resources Recommend Favorite

Locked Nucleic Acid Oligonucleotides: The Next Generation of Antisense Agents?

By Grünweller Arnold Hartmann Roland K.

BioDrugs, Vol. 21, Iss. 4, 2007-01 ,pp. : 235-243

Adis International

Access to resources Recommend Favorite

Comment on: A novel dysferlin‐mutant pseudoexon bypassed with antisense oligonucleotides

Annals Of Clinical And Translational Neurology, Vol. 2, Iss. 7, 2015-07 ,pp. : 783-784

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to comment on: A novel dysferlin mutant pseudoexon bypassed with antisense oligonucleotides

Annals Of Clinical And Translational Neurology, Vol. 2, Iss. 7, 2015-07 ,pp. : 785-785

John Wiley & Sons Inc

Access to resources Recommend Favorite